Estudio aleatorizado, con enmascaramiento doble y controlado con placebo para evaluar los efectos de EP547 en sujetos con prurito colestásico debido a colangitis biliar primaria o colangitis esclerosante primaria.

Datos básicos

Protocolo:: EP-547-201
EUDRACT:: 2021-002526-25
NCT:
Centro:: HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Año de incio:: 2023
Año de finalización:: 2024

ENSAYO CLÍNICO

Objetivos del proyecto

Objetivo Principal: •Evaluar la eficacia de EP547 en comparación con placebo para tratar el prurito, evaluado mediante la escala numérica de valoración del picor más intenso (WI-NRS) Objetivos Secundarios: •Evaluar la eficacia de EP547 en comparación con placebo en los siguientes aspectos: -Calidad de vida relacionada con el prurito mediante la escala de picor 5-D -Gravedad del prurito mediante la escala de impresión global del paciente sobre la gravedad (PGI-S) -Respuesta global del prurito al tratamiento mediante la escala de impresión global del paciente sobre el cambio (PGI-C) •Evaluar la seguridad y la tolerabilidad de EP547 •Evaluar la farmacocinética (FC) de EP547

Documentos

No hay documentos

Participantes

Isabel Conde Amiel

Investigador Colaborador
José Luis Poveda Andrés

Investigador Colaborador
Maria Perez Fernandez

Técnico Apoyo Investigación
Ángela Sofía Carvalho Gomes

Investigador Colaborador
Victoria Aguilera Sancho-Tello

Investigador Colaborador
Marina Berenguer Haym

Investigador Principal
Almudena Cubells García

Data Manager / Study Coordinator
Miriam Aurora Saiz Sigler

Técnico Apoyo Investigación

Grupos

Hepatología, Cirugia Hepatobiliopancreática y Trasplantes

Leader

Marina Berenguer Haym
Unidad de Descubrimiento de Fármacos (UDF)

Investigador Principal

Leonor Puchades Carrasco
Unidad mixta de investigación en enfermedades raras (CIPF)

Leader

José María Millán Salvador
Grupo de Investigación de Farmacia

Investigador Principal

Javier García Pellicer

Financiadores - Promotores

Escient Pharmaceuticals, Inc.

Resultados del Ensayo Clínico

Publicaciones en Revistas 143

Adaptation and validation of an abbreviated version of the SIPAT integrated psychosocial risk scale in patients with liver cirrhosis candidates for liver transplantation (SIPAT-11).

Garcia Morales, Natalia; (...); Cubiella, Joaquin

Article. 10.1016/j.gastrohep.2024.502220. 2024

Addressing the Burden and Management Strategies for Disparities and Inequities Among Liver Transplant Professionals: The ILTS Experience.

Andacoglu, Oya; (...); Selzner, Nazia

Article. 10.3389/ti.2023.11240. 2023

An international, multicenter, survey-based analysis of practice and management of acute liver failure.

Gurakar, Ahmet; (...); Coilly, Audrey

Article. 10.1097/LVT.0000000000000402. 2024

Anesthesia and Critical Care for the Prediction and Prevention for Small-for-size Syndrome: Guidelines from the ILTS-iLDLT-LTSI Consensus Conference.

Chadha, Ryan; (...); Rela, Mohamed

Article. 10.1097/TP.0000000000004803. 2023

Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA).

Pereyra-Rodríguez JJ; (...); Ortiz de Frutos FJ

Letter. 10.1111/jdv.19432. 2023

Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration.

Diaz-Gonzalez, Alvaro; (...); Londoño MC

Article. 10.1097/HEP.0000000000000018. 2023

CA125: a new biomarker in patients with Fontan circulation (vol 76, pg 112, 2023)

Fuentes, Francisco Buendia; (...); Soriano, Joaquin Rueda

Correction. 10.1016/j.rec.2023.03.018. 2023

Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease.

Simao, Andre Lopes; (...); Castro, Rui E

Article. 10.1016/j.jhepr.2023.100697. 2023

Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registries.

Garcia-Cortes, Miren; (...); Andrade, Raul J.

Article. 10.1111/liv.15623. 2023

CMV reactivation (rCMV) is associated with lower hepatocellular carcinoma (HCC) recurrence after liver transplatatoin (LT)

Aguilera, V.; (...); Berenguer, M.

Meeting Abstract. 2023

CMV reactivation after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study

Garcia-Garcia, Sonia; (...); Aguilera Sancho, Victoria

Meeting Abstract. 2023

COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls.

Kowdley KV; (...); Villamil A

Article. 10.14309/ajg.0000000000003029. 2024

Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

Montoro-Ronsano JB; (...); Soto-Ortega I

Article. 10.1016/j.farma.2023.01.003. 2023

Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

Montoro-Ronsano, Jose Bruno; (...); Soto-Ortega, Inmaculada

Article. 10.1016/j.farma.2023.04.002. 2023

Cybersecurity, a priority for pharmacy services in the age of artificial intelligence.

Hernández Marín CM, Monte-Boquet E, Poveda Andrés JL

Editorial Material. 10.1016/j.farma.2024.08.001. 2024

Cytomegalovirus reactivation is associated with lower hepatocelullar carcinoma recurrence rates after liver transplantation

Aguilera Sancho, Victoria; (...); Rodriguez-Peralvarez, Manuel

Meeting Abstract. 2023

Cytomegalovirus specific polyfunctional t-cells control CMV reactivation, after liver transplantation

Carvalho-Gomes, Angela; (...); Sancho, Victoria Aguilera

Meeting Abstract. 2024

Characterization of drug-induced liver injury associated with drug reaction with eosinophilia and systemic symptoms in two prospective DILI registries.

Medina-Caliz, Inmaculada; (...); Alvarez-Alvarez, Ismael

Article. 10.1007/s00204-023-03630-0. 2023

Determining value in the treatment of activated PI3Kdelta syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.

Abad, Maria Reyes; (...); Gil, Alicia

Article. 10.33393/grhta.2024.3041. 2024

Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis

Silvestre, Juan Francisco; (...); Serra-Baldrich, Esther

Article. 10.1002/jvc2.275. 2024

Development and validation of a scoring system to predict response to obeticholic acid in primary biliary cholangitis.

De Vincentis, Antonio; (...); Carbone, Marco

Article. 10.1016/j.cgh.2024.05.008. 2024

Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR-MASH score

Marti-Aguado, David; (...); Marti-Bonmati, Luis

Article. 10.1111/liv.15766. 2024

Does colectomy improve survival in patients with ulcerative colitis undergoing liver transplant for autoimmune liver diseases?

Trapero-Marugan, M.; (...); Cuervas-Mons, V.

Meeting Abstract. 2023

Early liver transplantation for acute alcoholic hepatitis In a spanish liver transplant center

Aguilera Sancho, Victoria; (...); Berenguer, Marina

Meeting Abstract. 2023

Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver Transplantation.

Cortesi, Paolo Angelo; (...); Belli, Luca Saverio

Article. 10.3389/ti.2023.10954. 2023

EFFECTIVENESS AND SAFETY OF SECOND-LINE THERAPY IN PRIMARY BILIARY CHOLANGITIS (PBC): A PROSPECTIVE MULTICENTER REAL-WORLD COHORT

Gomez-Dominguez, Elena; (...); Fernandez-Rodriguez, Conrado

Meeting Abstract. 2023

EFFICACY OF OBETICHOLIC ACID (OCA) VS PLACEBO AND EXTERNAL CONTROL (EC) ON CLINICAL OUTCOMES IN PRIMARY BILIARY CHOLANGITIS (PBC)

Kowdley, Kris V.; (...); Villamil, Alejandra

Meeting Abstract. 2023

Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society consensus conference.

Pollok, Joerg M.; (...); Spiro, Michael

Article. 10.1016/S2468-1253(22)00268-0. 2023

ESOT Consensus Platform for Organ Transplantation: Setting the Stage for a Rigorous, Regularly Updated Development Process.

Cillo U; (...); Selzner N

Review. 10.3389/ti.2022.10915. 2022

European Society for Organ Transplantation Consensus Statement on Biomarkers in Liver Transplantation.

Berenguer M; (...); Zubair H

Article. 10.3389/ti.2023.11358. 2023

Excess waitlist mortality and survival benefit of liver transplantation for patients with severe acute-on-chronic liver failure: Interim results of the CHANCE study

Gustot, Thierry; (...); Jalan, Rajiv

Meeting Abstract. 2024

Exchangeable copper for patients with Wilson disease at follow-up: rethinking normal ranges or changing methodology.

Marino, Zoe; (...); Berenguer, Marina

Article. 10.1097/HEP.0000000000001105. 2024

EXCHANGEABLE COPPER QUANTIFICATION FELLS BELOW NORMAL RANGE IN A HIGH PROPORTION OF PATIENTS WITH WILSON DISEASE DURING FOLLOW-UP

Mendez, Zoe Marino; (...); Berenguer, Marina

Meeting Abstract. 2024

Exchangeable copper quantification fells belownormal range in a high proportion of patients withWilson disease during follow-up

Marino, Zoe; (...); Berenguer, Marina

Meeting Abstract. 2024

Exploring pregnancy, breastfeeding and contraception among women with Wilson disease in Spain: results from the Spanish Wilson registry

Romero-Gutierrez, Marta; (...); Marino, Zoe

Meeting Abstract. 2023

External validation of models to predict hepatocellular carcinoma (HCC) in HCV SVR F3-F4 patients

Sahuco, Ivan; (...); Berenguer, Marina

Meeting Abstract. 2023

External validation of models to predict hepatocellular carcinoma in Hepatitis C Virus cured F3-F4 patients.

Carvalho-Gomes Â; (...); Berenguer M

Article. 10.1002/ueg2.12571. 2024

FibroScan compared to liver biopsy for accurately detecting recurrent hepatic steatosis and fibrosis after liver transplantation for metabolic dysfunction-associated steatohepatitis

Martinez-Arenas, Laura; (...); Berenguer, Marina

Meeting Abstract. 2024

FibroScan compared to liver biopsy for accurately detecting recurrent hepatic steatosis and fibrosis after liver transplantation for metabolic dysfunction-associated steatohepatitis

Martinez-Arenas, L.; (...); Berenguer, M.

Meeting Abstract. 2024

FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for MASH.

Martinez-Arenas, Laura; (...); Berenguer, Marina

Article. 10.1111/liv.16085. 2024

First nationwide genetic study on Wilson disease (Spanish Wilson registry): high diversity in mutations and in use of genetic evaluation, association with clinical data and influence on diagnosis and health costs

Alonso Castellano, Pablo; (...); Garcia-Villarreal, Luis

Meeting Abstract. 2023

Frailty changes after liver transplantation in the Spanish setting. Results from a Spanish multicentre prospective cohort study

Puchades, L.; (...); Berenguer, M.

Meeting Abstract. 2023

Frailty Changes After Liver Transplantation. Results From a Spanish Multicenter Prospective Cohort Study

Puchades, Lorena; (...); Berenguer, Marina

Article. 10.1097/TXD.0000000000001599. 2024

GEMA-Na and MELD 3.0 severity scores to address sex disparities for accessing liver transplantation: a nationwide retrospective cohort study.

Rodríguez-Perálvarez ML; (...); Gastaca M

Article. 10.1016/j.eclinm.2024.102737. 2024

Hepatorenal syndrome markedly impacts prognosis of patients with alcohol-associated hepatitis. Results from the spanish registry of alcohol-associated liver disease (REHALC)

Gratacos-Gines, Jordi; (...); Pose, Elisa

Meeting Abstract. 2024

Incidence of de novo tumors after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study

Chafer, Isabel Terol; (...); Sancho, Victoria Aguilera

Meeting Abstract. 2023

Incidence of de novo tumors after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study

Chafer, I. Terol; (...); Sancho-Tello, M. V. Aguilera

Meeting Abstract. 2023

Incidence of fungal and other opportunistic infections in patients with autoimmune hepatitis: a spanish multicentre study

Diaz-Gonzalez, Alvaro; (...); Crespo, Javier

Meeting Abstract. 2024

International Living Donor Liver Transplant Registry - Initial progress towards transparent reporting of outcomes

Kantsedikas, I.; (...); Rela, M.

Meeting Abstract. 2024

Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.

Pozo-Rosich P; (...); Irimia P

Article. 10.1186/s10194-024-01747-w. 2024

Lessons from population genomics for Wilson disease: Prevalence, penetrance of mutations, clinical implications and design of regional screening programmes

Alonso Castellano, Pablo; (...); Garcia-Villarreal, Luis

Meeting Abstract. 2023

Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice.

Gomez, E; (...); Fernandez-Rodriguez, C M

Article. 10.1111/apt.18004. 2024

Long-term prospective follow-up of a primary biliary cholangitis (PBC) multicenter cohort treated with Obeticholic Acid (OCA). Interaction effect of triple therapy with fibrates

Gomez-Dominguez, Elena; (...); Fernandez-Rodriguez, Conrado

Meeting Abstract. 2023

Low penetrance of frequent ATP7B mutations explains the low prevalence of Wilson disease. Lessons from real-life registries.

Alonso-Castellano, Pablo; (...); Garcia-Villarreal, Luis

Article. 10.1016/j.dld.2024.09.002. 2024

Main clinical characteristics and evolutionary events among patients suffering Wilson disease in Spain: first results from the Spanish Wilson registry

Marino, Zoe; (...); Castillo, Pilar

Meeting Abstract. 2023

Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update.

Ruiz-Arabi, Elisa; (...); Aguado, Jose Maria

Article. 10.1016/j.trre.2024.100875. 2024

Management of Established Small-for-size Syndrome in Post Living Donor Liver Transplantation: Medical, Radiological, and Surgical Interventions: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference.

Kirchner, Varvara A.; (...); Rela, Mohamed

Article. 10.1097/TP.0000000000004771. 2023

Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer.

Deek MP; (...); Sweeney C

Article. 10.1016/j.euo.2024.03.010. 2024

National Survey on the Use of Mobile Applications in Patients with Hemophilia and Other Coagulopathies

Eduardo Megias, Juan; (...); Poveda Andres, Jose Luis

Meeting Abstract. 10.1182/blood-2022-169938. 2022

New challenges of advanced therapies.

Megías-Vericat JE; (...); Poveda Andrés JL

Article. 10.1016/j.farma.2023.11.008. 2024

Nutritional status in hepatic encephalopathy and transjugular intrahepatic portosystemic shunt-TIPS, and strategies to improve the outcomes

Berenguer, M.

Review. 10.51821/86.2.11430. 2023

Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus

Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis

Article. 10.1097/MD.0000000000032208. 2022

ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requering a pass would be more likely to be reimbursed in Spain.

Poveda JL; (...); Badia X

Article. 10.1186/s13023-022-02610-4. 2023

Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes

Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor

Review. 10.3390/biology12091159. 2023

Optimization of treatment in patients with primary biliary cholangitis: Gamma-glutamyl transferase levels as an early prognostic marker for ursodeoxycholic acid response. Results from the ColHai registry

Fernandez-Gordon Sanchez, Flor M.; (...); Gomez-Dominguez, Elena

Meeting Abstract. 2024

Overcoming barriers to care for Delta infected patients

Bono, Ariadna; (...); Berenguer, Marina

Meeting Abstract. 2023

Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease.

Marques, Patrice; (...); Sanz, Maria-Jesus

Article. 10.3390/ijms24032313. 2023

Paediatric solid organ transplant recipients (SOTR) demonstrate greater serological response to initial SARS-CoV-2 vaccination than adult SOTR, and comparable rates of antibody degradation

Pilar Ballester, Maria; (...); Nicastro, Emanuele

Meeting Abstract. 2024

Post Living Donor Liver Transplantation Small-for-size Syndrome: Definitions, Timelines, Biochemical, and Clinical Factors for Diagnosis: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference.

Kow, Alfred Wei Chieh; (...); Ikegami, Toru

Article. 10.1097/TP.0000000000004770. 2023

PREDICTION OF BIOCHEMICAL RESPONSE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS TREATED WITH OBETICHOLIC ACID: DERIVATION AND EXTERNAL VALIDATION OF THE OCA RESPONSE SCORE (ORS)

De Vincentis, Antonio; (...); Carbone, Marco

Meeting Abstract. 2023

Predictive factors for decompensating events in patients with cirrhosis with primary biliary cholangitis under different lines of therapy.

Ampuero J; (...); Fernández-Rodríguez C

Article. 10.1097/HEP.0000000000000826. 2024

Predictive models of treatment benefit in patients with autoimmune hepatitis and decompensated cirrhosis at diagnosis

Arvaniti, Pinelopi; (...); Carlota Londono, Maria

Meeting Abstract. 2023

Presence of good humanization practices in the healthcare of patients with rare diseases in Pharmacy Services

Company Albir MJ, Poveda Andrés JL, Edo Solsona MD

Article. 10.1016/j.farma.2023.06.0131130. 2024

Preventing Small-for-size Syndrome in Living Donor Liver Transplantation: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference.

Hakeem AR; (...); Rela M

Article. 10.1097/TP.0000000000004769. 2023

Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guideline.

Awan, Ahmed Arslan Yousuf; (...); Jadoul, Michel

Article. 10.7326/M23-2391. 2023

Primary sclerosing cholangitis as an indication for liver transplantation. Results and conditioning factors: relationship with associated intestinal pathology

Fernandez, Ainhoa; (...); Salcedo, Magdalena

Meeting Abstract. 2023

Primary sclerosing cholangitis as an indication for liver transplantation. Results and conditioning factors: relationship with associated intestinal pathology

Fernandez-Yunquera, A.; (...); Salcedo, M. M.

Meeting Abstract. 2023

Prophylaxis for tuberculosis and pneumocystis jirovecii does not seem necessary in patients with autoimmune hepatitis treated with corticosteroid therapy: spanish multicentre study

Diaz-Gonzalez, Alvaro; (...); Crespo, Javier

Meeting Abstract. 2024

Protocol for an International Living Donor Liver Transplant Registry ! LDLTregistry.org

Turner, B.; (...); Salinas, C. Hidalgo

Meeting Abstract. 2023

Real-life effectiveness of voxilaprevir/sofosbuvir/velpatasvir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir

Ruiz-Cobo, Juan Carlos; (...); Lens, Sabela

Meeting Abstract. 2023

Recompensation following an episode of alcohol-associated hepatitis mostly occurs in the first year of follow-up and is related to Child-Pugh score, levels of GGT and platelets, and alcohol abstinence

Gratacos, Jordi; (...); Pose, Elisa

Meeting Abstract. 2023

Risk of decompensated cirrhosis in patients with primary biliary cholangitis under first, second and third-line therapies

Lucena, Ana; (...); Ampuero, Javier

Meeting Abstract. 2023

Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebocontrolled trial

Puente Sanchez, Angela; (...); Garcia Pagan, Juan Carlos

Meeting Abstract. 2023

Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant.

Mehta, Gautam; (...); Jalan, Rajiv

Article. 10.1097/HC9.0000000000000273. 2023

Significant heterogeneity in the diagnosis and long-term management of Wilson disease: Results from a large multicenter Spanish study

Berenguer, Marina; (...); GEMHEP

Article. 10.1016/j.gastrohep.2022.10.018. 2023

Similar rates of liver transplantation (LT) for acute liver failure (ALF) but changes in patient profiles in a Spanish multicentre cohort

Conde, I.; (...); Aguilera, V.

Meeting Abstract. 2023

Survey to evaluate the implementation of the recommendations on the comprehensive diagnosis of viral hepatitis in a single extraction: where are we?

Cabezas, Joaquin; (...); Crespo, Javier

Meeting Abstract. 2023

SURVEY TO EVALUATE THE IMPLEMENTATION OF THE RECOMMENDATIONS ON THE COMPREHENSIVE DIAGNOSIS OF VIRAL HEPATITIS IN A SINGLE EXTRACTION: WHERE ARE WE?

Cabezas, Joaquin; (...); Crespo Garcia, Javier

Meeting Abstract. 2023

The concentration of HDV-RNA correlates with the probability of developing clinical events in patients with chronic hepatitis D

Palom, Adriana; (...); Buti, Maria

Meeting Abstract. 2024

The global prospective observational study to evaluate the role of 'liver transplantation in patients with cirrhosis and severe acute-on-chronic liver failure (CHANCE)': study design, demographics and overall outcome

Gustot, Thierry; (...); Jalan, Rajiv

Meeting Abstract. 2024

The interaction between metabolic syndrome and alcohol consumption after an episode of alcohol-associated hepatitis is associated with increased mortality: results from de spanish registry of alcohol-associated liver disease (REHALC)

Gratacos-Gines, Jordi; (...); Pose, Elisa

Meeting Abstract. 2024

The Reality of Inadequate Patient Care and the Need for a Global Action Framework in Organ Donation and Transplantation.

Domínguez-Gil B; (...); Delmonico FL

Article. 10.1097/TP.0000000000004186. 2022

The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD).

Badia, Xavier; (...); Valles, Joan-Antoni

Article. 10.1186/s13023-024-03324-5. 2024

Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die.

Chovi-Trull, Maria; (...); Poveda-Andres, Jose Luis

Article. 10.1136/ejhpharm-2024-004184. 2024

Transaminase Pattern Over Time Is Not Associated with a More Aggressive Hepatic Evolution: Results from the AEEH Wilson Registry

Berenguer, Marina; (...); Marino, Zoe

Meeting Abstract. 2024

Validation of the gender-equity model for liver allocation (GEMA) in a nationwide cohort of liver transplant candidates in Spain

Rodriguez-Peralvarez, Manuel; (...); Gastaca, Mikel

Meeting Abstract. 2024

Validation of the liver frailty index as an adverse outcome predictor in the spanish liver transplant setting. Results from a spanish multicentre prospective cohort study.

Puchades, L.; (...); Berenguer, M.

Meeting Abstract. 2023

VALUE CRITERIA FOR OUTCOMES BASED MANAGED ENTRY AGREEMENT OF CAR-T IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) THROUGH MCDA

Poveda, J. L.; (...); Lizan, L.

Meeting Abstract. 2023

Variation in global living donor liver transplant surgical technique - early data from the International Living Donor Liver Transplant Registry (LDLTregistry.org)

Kantsedikas, I.; (...); Rela, M.

Meeting Abstract. 2024

Variation in global living donor liver transplant surgical technique: Early data from the International Living Donor Liver Transplant Registry

Kantsedikas, Ilya; (...); Rela, Mohamed

Meeting Abstract. 10.1097/01.tp.0001066152.18661.c6. 2024

Very low access to early liver transplantation (LT) for acute alcoholic hepatitis (AAH) in a setting of social psychiatric contraindications

Garcia Garcia, S.; (...); Aguilera, V.

Meeting Abstract. 2023

Waiting time dictates impact of frailty: A Spanish multicenter prospective study.

Puchades, Lorena; (...); Berenguer, Marina

Article. 10.1016/j.jhepr.2023.100840. 2023

Women are also disadvantaged in accessing transplant outside the United States: analysis of the spanish liver transplantation registry

Tejedor, Marta; (...); Berenguer, Marina

Meeting Abstract. 2024

Women Are Also Disadvantaged in Accessing Transplant Outside the United States: Analysis of the Spanish Liver Transplantation Registry.

Tejedor, Marta; (...); Berenguer, Marina

Article. 10.3389/ti.2024.12732. 2024

Worldwide variations in COVID-19 vaccination policies and practices in liver transplant settings: results of a multi-society global survey.

Di Maira, Tommaso; (...); Berenguer, Marina

Article. 10.3389/frtra.2023.1332616. 2023